ID
37939
Beschrijving
Study ID: 104864/627 Clinical Study ID: 104864/627 Study Title: An Open-label, Multicenter, Non-Comparative Phase II Study of the Combination of Intravenous Topotecan and Gemcitabine Administered Once Weekly for Three Weeks Every 28 Days as Second-line Treatment in Patients With Recurrent Platinum Sensitive Ovarian Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00061308 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan, Gemcitabine Study Indication: Peritoneal Cancer, Ovarian Cancer, Neoplasms, Ovarian, Fallopian Tube Cancer
Trefwoorden
Versies (1)
- 01-09-19 01-09-19 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
1 september 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Intravenous Topotecan and Gemcitabine as Second-line Treatment in Patients With Ovarian Cancer NCT00061308
Course 3 Prior to next Course (Day 25 - 28) - Review of Disease Status; Therapeutic Interventions; End of Course Eligibility; Unscheduled Laboratory Tests; Therapeutic Interventions Log
Beschrijving
Review of Disease Status
Alias
- UMLS CUI-1
- C0699749
- UMLS CUI-2
- C0699752
Beschrijving
Date of Assessment
Datatype
date
Alias
- UMLS CUI [1]
- C2985720
Beschrijving
Assessment not done
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0220825
- UMLS CUI [1,2]
- C1272696
Beschrijving
Mark only one
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0220825
- UMLS CUI [1,2]
- C2826287
Beschrijving
Date of Progression
Datatype
date
Alias
- UMLS CUI [1,1]
- C0242656
- UMLS CUI [1,2]
- C0011008
Beschrijving
Mark one
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0221198
- UMLS CUI [1,2]
- C1516048
- UMLS CUI [2]
- C4534461
Beschrijving
Therapeutic Interventions
Alias
- UMLS CUI-1
- C0808232
Beschrijving
End of Course Eligibility
Alias
- UMLS CUI-1
- C0013893
- UMLS CUI-2
- C0750729
- UMLS CUI-3
- C0444930
Beschrijving
Hemoglobin >= 9.0 g/dL [90 g/L] Neutrophils >= 1000 cells/mm3 [>= 1.0 x 10*9 /L] Platelets >= 100,000/mm3 [>= 100.0 x 10*9 /L] No clinically significant non-hematologic drug related toxicity If "Yes“, proceed to next course. If "No”, complete Unscheduled Laboratory Tests.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0013893
Beschrijving
Unscheduled Laboratory Tests - Hematology
Alias
- UMLS CUI-1
- C0022885
- UMLS CUI-2
- C3854240
- UMLS CUI-3
- C0474523
Beschrijving
Unscheduled Laboratory Tests - Hematology
Alias
- UMLS CUI-1
- C0022885
- UMLS CUI-2
- C3854240
- UMLS CUI-3
- C0474523
Beschrijving
Hematology Test
Datatype
integer
Alias
- UMLS CUI [1]
- C0018941
Beschrijving
Hematology - No Result
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0018941
- UMLS CUI [1,2]
- C1274040
Beschrijving
Hematology - Value
Datatype
text
Alias
- UMLS CUI [1]
- C0474523
Beschrijving
Hematology - Value out of range and NOT clinically significant
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0474523
- UMLS CUI [1,2]
- C0438215
- UMLS CUI [1,3]
- C2826293
Beschrijving
Hematology - Value out of range and clinically significant
Datatype
integer
Alias
- UMLS CUI [1,1]
- C0474523
- UMLS CUI [1,2]
- C0438215
- UMLS CUI [1,3]
- C2826293
Beschrijving
Therapeutic Interventions
Alias
- UMLS CUI-1
- C0808232
Beschrijving
Line Number
Datatype
integer
Alias
- UMLS CUI [1]
- C0449788
Beschrijving
Procedure
Datatype
text
Alias
- UMLS CUI [1]
- C2700391
Beschrijving
Procedure details
Datatype
text
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C1522508
Beschrijving
Procedure Time
Datatype
time
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C0040223
Beschrijving
Procedure Date
Datatype
date
Alias
- UMLS CUI [1,1]
- C2700391
- UMLS CUI [1,2]
- C0011008
Similar models
Course 3 Prior to next Course (Day 25 - 28) - Review of Disease Status; Therapeutic Interventions; End of Course Eligibility; Unscheduled Laboratory Tests; Therapeutic Interventions Log
C0600091 (UMLS CUI [1,2])
C0699752 (UMLS CUI-2)
C1272696 (UMLS CUI [1,2])
C2826287 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C1516048 (UMLS CUI [1,2])
C4534461 (UMLS CUI [2])
C0013221 (UMLS CUI [2,1])
C0304229 (UMLS CUI [2,2])
C0750729 (UMLS CUI-2)
C0444930 (UMLS CUI-3)
C3854240 (UMLS CUI-2)
C0474523 (UMLS CUI-3)
C1302413 (UMLS CUI [1,2])
C3258037 (UMLS CUI [1,2])
C3854240 (UMLS CUI-2)
C0474523 (UMLS CUI-3)
C1274040 (UMLS CUI [1,2])
C0438215 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0438215 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C1522508 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
Geen commentaren